The article has been automatically translated into English by Google Translate from Russian and has not been edited.
Переклад цього матеріалу українською мовою з російської було автоматично здійснено сервісом Google Translate, без подальшого редагування тексту.
Bu məqalə Google Translate servisi vasitəsi ilə avtomatik olaraq rus dilindən azərbaycan dilinə tərcümə olunmuşdur. Bundan sonra mətn redaktə edilməmişdir.

One of the participants in the COVID-19 vaccine trial died: the study was not suspended

On Wednesday, October 21, Brazilian health authority Anvisa announced that a volunteer involved in a trial of a COVID-19 vaccine being developed by AstraZeneca and the University of Oxford has died. An investigation into the exact cause of death is underway; vaccine trials have not yet been suspended. Details told the publication Fox News.

Photo: Shutterstock

Local media reported that the deceased was a man from Rio de Janeiro, he was about 20 years old. It is not yet known whether the man was vaccinated or was part of the placebo group.

An anonymous source said that if the victim had been vaccinated, the research would have been suspended.

A spokesman for AstraZeneca said the company was unable to comment on individual cases in the ongoing COVID-19 vaccine trial due to regulations. However, he stressed that the company has completed all the necessary verification procedures.

“All significant medical events are carefully assessed by trial researchers, an independent safety monitoring committee and regulatory bodies,” the spokesman said. "These assessments have raised no concerns about continuing the current study."

On the subject: A vaccine that partially protects against COVID-19 already exists

In the U.S. clinical trials of AstraZeneca are suspended pending investigation by the US Food and Drug Administration (FDA) due to a "possible serious adverse event" in one of the volunteers. The head of the Department of Health and Human Services, Alex Azar, told reporters that he was not aware of any plans to reopen the trials as the case is still pending with the FDA.

In June, Brazil announced a deal to buy 100 million doses of a potential COVID-19 vaccine if it is found to be safe and effective. At the time, Brazilian President Jair Bolsonaro, who had recovered from COVID-19 himself, said the money was meant to be invested in research and purchase of a "batch of vaccines."

The country ranks second in the world in the number of deaths associated with coronavirus, and the third in the number of infected (more than 5,3 million cases).

Miscellaneous vaccine Incidents coronavirus Special Projects

Read also on ForumDaily:

Covidiot and coronicles: 7 new words that emerged during the pandemic

Three months or longer: who and why is the protracted course of COVID-19 threatened

Scientists have discovered a new feature of COVID-19 that changes the perception of the disease

Card, money and smartphone: coronavirus can live on some surfaces for up to 4 weeks

A vaccine that partially protects against COVID-19 already exists

CDC recognizes another way coronavirus spreads

WHO: there may be 20 times more people infected with coronavirus than officially recognized

Do you want more important and interesting news about life in the USA and immigration to America? Subscribe to our page in Facebook. Choose the "Display Priority" option and read us first. And don't forget to subscribe to ForumDaily Woman and ForumDaily New York - there you will find a lot of interesting and positive information. 



 
1065 requests in 2,706 seconds.